Analyst Price Target is $3.94
▲ +319.91% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Lucid Diagnostics in the last 3 months. The average price target is $3.94, with a high forecast of $7.25 and a low forecast of $2.50. The average price target represents a 319.91% upside from the last price of $0.94.
Current Consensus is
Buy
The current consensus among 5 contributing investment analysts is to buy stock in Lucid Diagnostics. This Buy consensus rating has held steady for over two years.